United Kingdom Cancer Diagnostics Market, By Product (Consumables v/s Instruments), By Technology (IVD Testing, Imaging, Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Others), By End User, By Region, Competition Forecast & Opportunities, 2027

Report
72 Pages
July 2022
Region: United Kingdom
TechSci Research
ID: 5624444

United Kingdom cancer diagnostics market is expected to witness robust growth in the forecast period. Cancer diagnostics is a process of identifying different proteins, biomarkers, or any other signs that can reveal the presence of a cancerous tumor in the body. Diagnostic testing is a crucial process that can validate or eliminate the existence of an illness and monitor the stage of the disease. It helps the healthcare professionals to decide the course of action and predict and review the treatment outcomes. The diagnostic procedures which help the patients to identify cancer are laboratory tests, surgery, genetic testing, tumor biopsy, imaging, or endoscopic testing. Factors such as the rise in consumer awareness about the benefits of early diagnosis and treatment and the increase in the number of diagnostic laboratories are primarily driving the growth of the United Kingdom cancer diagnostics market in the forecast period. Increased adoption of unhealthy eating habits and a sedentary lifestyle has escalated the occurrence of cancer across the country.

United Kingdom cancer diagnostics market is segmented into product, technology, application, end user, regional distribution, and Competitive Landscape.

Based on product, the market is bifurcated into consumables and instruments. Consumables are dominating the market and are expected to maintain their dominance over the next five years owing to the rise in the adoption of consumables for cancer diagnostics and high-end investments for research and development activities. The launch of technologically advanced kits & reagents in the market and the growing old age population are the other prominent drivers expected to drive the segment demand.

Based on technology, the market is divided into IVD testing, imaging, and biopsy. Imaging technology is expected to account for a significant market share in the forecast period. By using imaging technology, healthcare professionals can easily decide the course of action. The constant rise in the number of cancer patients is accelerating the demand for imaging modalities in the country.

GE Healthcare UK Limited, Becton, Dickinson U.K. Limited, Roche Diagnostics UK, Abbott Laboratories Limited, Fujifilm Healthcare UK Limited, Hologic (UK) Limited, Agilent Technologies UK Limited, are the major market players operating in the United Kingdom cancer diagnostics market.

Years considered for this report:

Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F-2027F

Objective of the Study:

To analyze the historical growth in the market size of the United Kingdom Cancer diagnostics market from 2017 to 2021.
To estimate and forecast the market size of United Kingdom Cancer diagnostics market from 2022E to 2027F and growth rate until 2027F.
To classify and forecast the United Kingdom Cancer diagnostics market based on product, technology, application, end user, region, and company.
To identify the dominant region or segment in the United Kingdom Cancer diagnostics market.
To identify drivers and challenges for the United Kingdom Cancer diagnostics market.
To examine competitive developments such as expansions, mergers & acquisitions, etc., in the United Kingdom Cancer diagnostics market.
To identify and analyze the profiles of leading players operating in the United Kingdom Cancer diagnostics market.
To identify key sustainable strategies adopted by market players in United Kingdom Cancer diagnostics market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of companies across the country. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the comapnies, which could not be identified due to the limitations of secondary research. The publisher analyzed the presence of all major players across the country.

The publisher calculated the market size of the United Kingdom Cancer diagnostics market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the publisher.

Key Target Audience:

Cancer diagnostics service providers
Market research and consulting firms
Government bodies such as regulating authorities and policy makers
Organizations, forums, and alliances related to Cancer diagnostics

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, vendor and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, United Kingdom cancer diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below: